ArticleDiagnostics (Basel, Switzerland)2024
Federated Learning with Privacy Preserving for Multi- Institutional Three-Dimensional Brain Tumor Segmentation.
Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- AI Privacy and Security in Healthcare: A Systematic Literature Review.International journal of telerehabilitation · 2026Article
- Artificial intelligence in haematology laboratory diagnosis: Current applications, challenges, and future directions.African journal of laboratory medicine · 2026Review
- Article
- Empowering photodynamic therapy with artificial intelligence: current trends and future directions.Frontiers in oncology · 2026Review
- Multi-omics profiling and AI-driven clinically deployable risk models in MGUS and smoldering myeloma.Clinical and experimental medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesBrain tumors are complex diseases that require careful diagnosis and treatment. A minor error in the diagnosis may easily lead to significant consequences. Thus, one must place a premium on accurately identifying brain tumors. However, deep learning (DL) models often face challenges in obtaining sufficient medical imaging data due to legal, privacy, and technical barriers hindering data sharing between institutions. This study aims to implement a federated learning (FL) approach with privacy-preserving techniques (PPTs) directed toward segmenting brain tumor lesions in a distributed and privacy-aware manner.
methodsThe suggested approach employs a model of 3D U-Net, which is trained using federated learning on the BraTS 2020 dataset. PPTs, such as differential privacy, are included to ensure data confidentiality while managing privacy and heterogeneity challenges with minimal communication overhead. The efficiency of the model is measured in terms of Dice similarity coefficients (DSCs) and 95% Hausdorff distances (HD95) concerning the target areas concerned by tumors, which include the whole tumor (WT), tumor core (TC), and enhancing tumor core (ET).
resultsIn the validation phase, the partial federated model achieved DSCs of 86.1%, 83.3%, and 79.8%, corresponding to 95% values of 25.3 mm, 8.61 mm, and 9.16 mm for WT, TC, and ET, respectively. On the final test set, the model demonstrated improved performance, achieving DSCs of 89.85%, 87.55%, and 86.6%, with HD95 values of 22.95 mm, 8.68 mm, and 8.32 mm for WT, TC, and ET, respectively, which indicates the effectiveness of the segmentation approach, and its privacy preservation.
conclusionThis study presents a highly competitive, collaborative federated learning model with PPTs that can successfully segment brain tumor lesions without compromising patient data confidentiality. Future work will improve model generalizability and extend the framework to other medical imaging tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.